Basics Design Therapeutics, Inc. IPO Date: March 29, 2021 Sector: Healthcare Industry: Biotech Market Cap: $367.32M Activated in VL: True Average Daily Range Avg Daily Range: $0.35 | 3.55% Avg Daily Range (30 D): $0.18 | 3.80% Avg Daily Range (90 D): $0.16 | 3.85% Institutional Daily Volume Avg Daily Volume: .23M Avg Daily Volume (30 D): .12M Avg Daily Volume (90 D): .09M Trade Size Avg Trade Size (Sh.): 90 Avg Trade Size (Sh.) (30 D): 95 Avg Trade Size (Sh.) (90 D): 79 Institutional Trades Total Inst.Trades: 267 Avg Inst. Trade: $1.65M Avg Inst. Trade (30 D): $2.95M Avg Inst. Trade (90 D): $1.73M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.38M Avg Closing Trade (30 D): $1.7M Avg Closing Trade (90 D): $1.7M Avg Closing Volume: 186.59K     News May 7, 2024 @ 10:30 AM Design Therapeutics to Participate in the 2024 RBC... Source: Design Therapeutics, Inc. Mar 26, 2024 @ 11:37 AM Design Therapeutics And 2 Other Stocks Under $5 In... Source: Avi Kapoor Mar 19, 2024 @ 8:01 PM Design Therapeutics Outlines Progress Across GeneT... Source: Design Therapeutics, Inc. Mar 12, 2024 @ 10:30 AM Design Therapeutics to Webcast Fourth Quarter and ... Source: Design Therapeutics, Inc. Dec 18, 2023 @ 5:00 PM Design Therapeutics, Inc. (DSGN) Upgraded to Buy: ... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.12 $-.34 $-.31 Diluted EPS $-1.12 $-.34 $-.31 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -63.49M $ -19.08M $ -17.72M Operating Income / Loss $ -74.93M $ -21.57M $ -20.42M Cost of Revenue $ $ $ Net Cash Flow $ -26M $ 6.04M $ -8.9M PE Ratio